CD Biosynsis offers high-precision Synechococcus spp. Gene Knock-in Services, providing a robust platform for the site-specific integration of exogenous DNA into the genome of these industrially significant cyanobacteria. Unlike random integration, which often leads to unpredictable expression levels and potential disruption of vital cellular functions, our knock-in technology utilizes CRISPR-mediated Homology-Directed Repair (HDR). This ensures that transgenes—whether they are metabolic pathways, fluorescent reporters, or therapeutic proteins—are inserted into pre-validated genomic "Neutral Sites" (NS), allowing for stable, high-level expression without affecting host fitness.
Our service is specifically engineered to address the unique biological constraints of Synechococcus, such as its polyploid nature and the requirement for efficient chromosomal segregation. By employing advanced donor template designs and optimized cyanobacterial regulatory elements (promoters and RBS), we facilitate the seamless integration of large genetic cassettes. Whether you are aiming to engineer "photosynthetic cell factories" for the production of isobutanol, sucrose, or high-value pigments, our end-to-end solutions provide the technical expertise and analytical verification necessary to achieve your research and production goals.
Get a QuoteAchieving predictable transgene expression in Synechococcus species like S. elongatus PCC 7942 or Synechococcus sp. PCC 7002 has historically been a challenge due to the need for full segregation across multiple genome copies. Our CRISPR-Cas9/HDR-mediated knock-in platform solves this by directing the integration of your Gene of Interest (GOI) to specific, well-characterized Neutral Sites. These are genomic regions where the insertion of foreign DNA does not disrupt essential genes or photosynthetic efficiency, ensuring consistent expression across generations.
Our platform is meticulously optimized for the cyanobacterial intracellular environment. We utilize proprietary codon-optimization matrices to ensure that both the CRISPR machinery and the integrated transgenes are translated efficiently. By integrating your pathways into validated NS loci (e.g., NS1 or NS2), we protect the transgenes from the epigenetic silencing mechanisms often seen with random integration. This precision allows for the maintenance of high metabolic flux, critical for the conversion of CO2 and solar energy into target bioproducts at industrial scales.
We provide a variety of knock-in strategies tailored to the specific functional requirements of your project, from simple protein tagging to complex pathway assembly.
Locus Selection
Targeting validated regions like NS1, NS2, or chromosomal "safe harbors" that support high transcriptional activity without disrupting native circadian rhythms or growth.
Stable Inheritance
Ensuring full chromosomal segregation using CRISPR-mediated selective pressure to create homozygous knock-in strains.
Localization Studies
Site-specific insertion of fluorescent proteins (e.g., GFP, YFP) at the C- or N-terminus of endogenous genes to study protein dynamics in the thylakoid membrane or carboxysomes.
Affinity Tags
Insertion of FLAG, HA, or His tags to facilitate protein purification and the study of protein-protein interactions within the native cyanobacterial context.
Multi-Gene KI
Simultaneous integration of multiple enzymes to create new biosynthetic routes, such as pathways for the synthesis of bioplastics (PHB) or specialty chemicals.
Regulatory Tuning
Utilizing a library of cyanobacterial promoters (constitutive or inducible) to fine-tune the expression levels of each gene within the integrated pathway.
Our rigorous workflow ensures the precise delivery of engineered strains with full genomic transparency and functional verification.
1. Computational Design
2. Build & Tool Prep
3. Transformation & Segregation
4. Verification & Delivery
Selection of the optimal Neutral Site and bioinformatic gRNA design. Full codon optimization of the transgene sequence to match the specific Synechococcus host bias.
Synthesis of HDR donor templates with high-fidelity homology arms. Preparation of Cas9/Cas12a vectors (integrative or replicative). For large inserts, we optimize donor concentration to maximize HDR efficiency.
Genotyping: Confirmation of site-specific integration and full segregation via junction PCR and Sanger/NGS sequencing. Phenotypic Characterization: Verification of functional expression and growth stability. Delivery of cryopreserved strains.
Rapid Segregation
By leveraging CRISPR selective pressure, we reduce the time required to reach homozygous status in polyploid Synechococcus strains by up to 70%.
Large Cassette Capacity
Our platform is capable of integrating large multi-gene metabolic pathways (up to 10 kb+), enabling complex synthetic biology projects in cyanobacteria.
Validated Neutral Sites
Access to a library of pre-validated Neutral Sites to ensure that transgene integration does not interfere with native growth or photosynthesis.
Scarless Modifications
Advanced marker-excision protocols allow for the construction of multi-gene mutants without residual antibiotic resistance markers.
1. Why is CRISPR-mediated knock-in better than random integration for cyanobacteria?
Random integration often leads to gene silencing or variable expression due to position effects. CRISPR-mediated knock-in at Neutral Sites ensures stable, predictable expression and allows for accelerated segregation in polyploid hosts.
2. How do you handle the polyploid nature of Synechococcus?
We utilize the CRISPR nuclease to actively target and eliminate wild-type chromosomal copies. This "active selection" forces the cell to only maintain the edited genome copies, ensuring homozygous mutants.
3. What is the typical size limit for a gene knock-in?
While smaller inserts are more efficient, we have successfully integrated cassettes up to 8-10 kb in size using optimized donor templates and high-efficiency delivery methods.
4. Do you provide help with selecting promoters and RBS?
Yes, we offer a library of validated cyanobacterial promoters (e.g., Ptrc, PpsbAII) and ribosome binding sites (RBS) to ensure the desired expression level for your transgene.
5. How do you verify site-specific integration and full segregation?
We perform junction PCR using primers that span the border between the host genome and the donor DNA. A single band of the edited size (without a wild-type band) confirms full segregation.
6. Can you perform knock-in in marine Synechococcus strains?
Yes, we have established protocols for marine strains like Synechococcus sp. PCC 7002, utilizing triparental conjugation for efficient DNA delivery.
7. Are the engineered strains marker-free?
We can utilize "scarless" methods or selection markers that can be excised via recombinase systems to provide strains free of antibiotic resistance genes.
8. What is the typical turnaround time for a knock-in strain?
A standard knock-in project from computational design to the delivery of a verified homozygous strain typically takes between 10 to 14 weeks.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.